No epidemiological evidence for infant vaccinations to cause allergic disease.

PubWeight™: 2.13‹?› | Rank: Top 2%

🔗 View Article (PMID 15308362)

Published in Vaccine on September 03, 2004

Authors

S Koppen1, R de Groot, H J Neijens, N Nagelkerke, W van Eden, H C Rümke

Author Affiliations

1: Vaxinostics, Vaccine Center Erasmus University Rotterdam, C/o Erasmus MC--Sophia Children's Hospital, Secretariat Pediatric Infectious Diseases and Immunology, Room Sp 3533, P.O. Box 2060, 3000 CB Rotterdam, The Netherlands.

Articles by these authors

A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet (1994) 3.50

Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A (1985) 3.31

T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet (1986) 3.20

[Chickenpox: sufficient reasons for the introduction of vaccination]. Ned Tijdschr Geneeskd (2006) 2.61

Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol (1995) 2.55

Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis (1997) 2.32

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol (1987) 2.24

Antigenic relatedness of a strongly immunogenic 65 kDA mycobacterial protein antigen with a similarly sized ubiquitous bacterial common antigen. Microb Pathog (1988) 2.23

Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. J Antimicrob Chemother (2000) 2.14

T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum (1985) 2.06

Bronchial responsiveness as a function of inhaled histamine and the methods of measurement. Bull Eur Physiopathol Respir (1982) 2.06

Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03

Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol (1996) 2.00

Influenza types and patient population. Lancet (1995) 1.94

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis (1999) 1.87

Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J (2001) 1.81

Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol (1998) 1.73

Association of consumption of products containing milk fat with reduced asthma risk in pre-school children: the PIAMA birth cohort study. Thorax (2003) 1.72

Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69

Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med (1992) 1.68

The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol (2001) 1.62

Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis (2003) 1.59

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine (1996) 1.54

Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med (1995) 1.53

Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS (1990) 1.51

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis (1997) 1.51

Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection. Infect Immun (2001) 1.50

Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms. J Clin Microbiol (1998) 1.47

A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol (2000) 1.46

Pathophysiology of meningococcal sepsis in children. Eur J Pediatr (1998) 1.46

CD4+ cells proliferate after peanut-extract-specific and CD8+ cells proliferate after polyclonal stimulation of PBMC of children with atopic dermatitis. Clin Exp Allergy (1998) 1.46

Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy (2003) 1.46

Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 1.45

Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat (2008) 1.45

Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43

On some novel aspects of consanguineous marriages. Public Health Genomics (2010) 1.42

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation (2006) 1.41

Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study. BMJ (1998) 1.40

Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol (1998) 1.40

Occurrence of a late response to exercise in asthmatic children: multiple regression approach using time-matched baseline and histamine control days. Eur Respir J (1996) 1.40

Comparison of five methods of malaria detection in the outpatient setting. Am J Trop Med Hyg (1999) 1.39

[Respiratory syncytial virus infections and preventive options]. Ned Tijdschr Geneeskd (2000) 1.39

[A measles epidemic in an adequately vaccinated middle school population]. Ned Tijdschr Geneeskd (1994) 1.39

[The diphtheria epidemic in the Russian Federation and recommendations concerning diphtheria vaccination in The Netherlands]. Ned Tijdschr Geneeskd (1994) 1.39

[Osteomyelitis as a complication following BCG vaccination]. Ned Tijdschr Geneeskd (1995) 1.39

Ichthyosis, exocrine pancreatic insufficiency, impaired neutrophil chemotaxis, growth retardation, and metaphyseal dysplasia (Shwachman syndrome). Report of a case with extensive skin lesions (clinical, histological, and ultrastructural findings) Arch Dermatol (1991) 1.38

Inflammatory disease processes and interactions with nutrition. Br J Nutr (2009) 1.34

Baseline and previous physical activity in relation to mortality in elderly men: the Zutphen Elderly Study. Am J Epidemiol (1999) 1.33

Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr (2001) 1.31

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31

Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women. J Clin Microbiol (2005) 1.31

HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30

Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol (2001) 1.29

Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors. J Clin Microbiol (1998) 1.29

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet (1999) 1.28

HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun (2000) 1.28

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol (1997) 1.24

Mortality among tuberculosis patients in The Netherlands in the period 1993-1995. Eur Respir J (1998) 1.23

The effect of age and study duration on the relationship between 'clustering' of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to recent transmission. Epidemiol Infect (2001) 1.22

Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun (2002) 1.21

Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20

HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19

The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun (2004) 1.17

Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol (1994) 1.17

Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Br Med J (Clin Res Ed) (1984) 1.16

Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones. J Clin Microbiol (1999) 1.15

Analysing collaborative trials for qualitative microbiological methods: accordance and concordance. Int J Food Microbiol (2002) 1.15

Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol (1998) 1.15

Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr (1998) 1.15

Respiratory infections in infants: interaction of parental allergy, child care, and siblings-- The PIAMA study. Pediatrics (2001) 1.15

Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol (2001) 1.14

Prevalence and incidence of hepatitis A among male homosexuals. Br Med J (Clin Res Ed) (1983) 1.14

Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol (1990) 1.14

Relationship between clinical severity of respiratory syncytial virus infection and subtype. Arch Dis Child (1996) 1.14

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med (1992) 1.12

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years. Vaccine (2011) 1.12

Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res (1993) 1.11

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A (1997) 1.10

Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy (2001) 1.10

Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia (1997) 1.10

Age-dependent pharmacokinetics of lamivudine in HIV-infected children. Clin Pharmacol Ther (2007) 1.10

Validation of ISO method 11290 part 1--detection of Listeria monocytogenes in foods. Int J Food Microbiol (2001) 1.10

The role of nitric oxide in bacterial meningitis in children. J Infect Dis (1996) 1.10

The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum (2003) 1.09

A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol (1989) 1.09

Infection with cytomegalovirus in homosexual men. Br J Vener Dis (1984) 1.08

[Epidemiological characteristics of reported HIV-1 infection in children in the Netherlands, 1998-2000: vertical transmission via parents from countries with a generalised epidemic]. Ned Tijdschr Geneeskd (2002) 1.08

The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV). Virus Res (1987) 1.07